Home R&D

R&D

Biogen and Bio-Thera Solutions to develop Actemra biosimilar
Featured

Biogen and Bio-Thera Solutions to develop Actemra biosimilar

Dominic Cuthbert -
0
Trial shows leishmaniasis vaccine safe and induces immune responses in patients
Featured

Trial shows leishmaniasis vaccine safe and induces immune responses in patients

Tess Egginton -
0
Claritas to expand R-107 program to include treatment of sepsis
Featured

Claritas to expand R-107 program to include treatment of sepsis

Dominic Cuthbert -
0
Moderna & Catalent expand collaboration
Featured

Moderna & Catalent expand collaboration

Dominic Cuthbert -
0
Pfizer-BioNTech COVID-19 vaccine maintains efficiency in latest results
Featured

Pfizer-BioNTech COVID-19 vaccine maintains efficiency in latest results

Dominic Cuthbert -
0
Novavax initiates COVID-19 vaccine clinical trial crossover
Featured

Novavax initiates COVID-19 vaccine clinical trial crossover

Dominic Cuthbert -
0
Phase 2 trial evaluating Bamlanivimab with VIR-7831 against COVID-19 yields positive topline data
Featured

Phase 2 trial evaluating Bamlanivimab with VIR-7831 against COVID-19 yields positive topline data

Dominic Cuthbert -
0
Pfizer initiates Phase 1 study of novel oral antiviral therapeutic agent against SARS-CoV-2
Featured

Pfizer initiates Phase 1 study of novel oral antiviral therapeutic agent against SARS-CoV-2

Dominic Cuthbert -
0
Self-administered inhaled painkiller shows superiority in prehospital setting
Featured

Self-administered inhaled painkiller shows superiority in prehospital setting

Dominic Cuthbert -
0
IONTAS identifies novel SARS-CoV-2 neutralising antibodies which bind to new variants
Featured

IONTAS identifies novel SARS-CoV-2 neutralising antibodies which bind to new variants

Tess Egginton -
0
123...183Page 1 of 183

© 2020 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks